Collas Crill's Corporate Finance and Funds team in Guernsey has advised on the launch of Alpha Investment Funds PCC, a registered, closed-ended private investment fund.
The law firm's team, including Partner Paul Wilkes and Senior Associate Gareth Morgan, has also advised on the proposed creation of the fund's first cell.
The new fund uses the Guernsey protected cell fund structure, which allows the creation of a number of 'cells' or funds within a fund.
The first cell, Alpha Life Sciences Fund (ALS), which is managed by Guernsey licensee Alpha Management, will look to invest in opportunities in the healthcare, medical technology and pharmaceutical sectors.
The intention is to create more cells in the future to pursue opportunities in the cleantech, biotech, environmental and innovation spaces.